期刊文献+

p120连环素与上皮性钙粘附蛋白在基底细胞样乳腺癌中表达的临床意义 被引量:1

Expressions of p120 Catenin and E-Cadherin and Their Clinical Significance in Basal-Like Breast Cancer
下载PDF
导出
摘要 目的探讨p120连环素(p120)与上皮性钙粘附蛋白(E-cad)在基底细胞样乳腺癌(BLBC)中表达的临床意义。方法采用免疫组织化学法,观察p120、E-cad在56例BLBC患者中的表达与发病年龄、肿瘤大小、组织学分级、淋巴结转移和pTNM分期的关系以及p120和E-cad表达的相关性。结果①p120在年龄分组中表达差异无统计学意义;在肿瘤大小分组、组织学分级分组、淋巴结转移分组、pTNM分期分组中表达差异均有统计学意义。②E-cad在年龄分组、肿瘤大小分组中表达差异均无统计学意义;在组织学分级分组、淋巴结转移分组、pTNM分期分组中表达差异均有统计学意义。③在BLBC中p120异常表达与E-cad表达减弱/消失的相关性有统计学意义。结论在BLBC中,p120异常表达与E-cad表达减弱/消失均提示预后不良,两者的表达有正相关性。 Objective To investigate the expressions and significance of p120 catenin and E-cadherin (E-cad) in basal-like breast cancer (BLBC). Methods Immunohistochemical method was performed to determine the relationship between expressions ofpl20 catenin, E-cad in 56 cases of basal-like breast cancer and their clinicopathological characteristics. Results (2)p 120 expression was not statistically significantly different in different ages. The different expression of p120 was significantly associated with tumor size, histological grade, lymph node status and pTNM stage. (~)E-cad expression was not statistically significantly different in different ages and tumor sizes. The different expression of E-cad was significantly associated with histological grade, lymph node status and pTNM stage. (~ The aberrant expression of p120 and the attenuated/absent expression of E-cad were correlated in basal-like breast cancer, with statistical significance. Conclusions The aberrant expression of p120 and the attenuated/absent expression of E-cad are positively correlated, probably indicating unfavorable prognosis in basal-like breast cancer.
出处 《临床医学工程》 2014年第3期353-354,357,共3页 Clinical Medicine & Engineering
关键词 乳腺肿瘤 基底细胞样 p120连环素 上皮性钙粘附蛋白 Breast neoplasm Basal-like p 120 catenin E-cadherin
  • 相关文献

参考文献17

  • 1刘慧,范钦和,李霄,刘广珍.基底细胞样型乳腺癌的临床病理特点和预后意义[J].中华病理学杂志,2009,38(5):316-322. 被引量:10
  • 2赵晶,付丽.乳腺癌的分子分型[J].中华乳腺病杂志(电子版),2009,3(2):35-40. 被引量:34
  • 3Cheung LW, Leung PC, Wong AS. Cadherin switching and activation of p120 catenin signaling are mediators of gonadotropin-releasing hor- mone to promote tumor cell migration and invasion in ovarian cancer [J] . Oncogene, 2010, 29 (16) : 2427-2440.
  • 4杨丽娟,刘玉琴,顾蓓,卞晓翠,冯海凉,杨振丽,刘艳艳.人乳腺癌细胞系中上皮型钙黏连蛋白表达对其黏附和增殖的影响[J].中华病理学杂志,2010,39(12):842-847. 被引量:8
  • 5Chetty R, Jain D, Serra S. p120 catenin reduction and cytoplasmic relo- calization leads to dysregulation of E-eadherin in solid pseudopapillary tumors of the pancreas [J] . Am JClin Pathol, 2008, 130 (1) : 71-76.
  • 6唐平,魏兵,David G. Hicks,Kristin Skinner,步宏.乳腺癌的分子分类及其临床应用[J].中华病理学杂志,2009,38(1):13-17. 被引量:24
  • 7Goldhirsch A, Glick JH, Gelber RD, et al. Meeting highlights: interna tional expert consensus on the primary therapy of early breast cancer 2005 [J] . Ann Oncol, 2005, 16 (10) : 1569-1583.
  • 8Nielsen TO, Hsu FD, Jensen K, et aL Immunohistochemical and clini- cal characterization of the basal-like subtype of invasive breast carci- noma [J] . Clin Cancer Res, 2004, 10 (16) : 5367-5374.
  • 9Livasy CA, Karaca G, Nanda R, et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma [ J] . Mod Pathol, 2006, 19 (2) : 264-271.
  • 10WHO世界卫生组织肿瘤分类及诊断标准系列.乳腺及女性生殖器官肿瘤病理学和遗传学[M].北京:人民卫生出版社,2006:53.

二级参考文献93

  • 1陈萍,韩影,张玉华,朴颖实,李弘,张伟东.乳腺癌中E-cadherin的表达及其临床病理意义[J].临床与实验病理学杂志,2004,20(6):715-717. 被引量:5
  • 2Ma XJ, Wang Z, Ryan PD, et al. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell, 2004, 5(6): 607-616.
  • 3Fan C, Oh DS, Wessels L, et al. Concordance among gene- expression-based predictors for breast cancer. N Engl J Med, 2006, 355(6) : 560-569.
  • 4Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature, 2000, 406 (6797) : 747-752.
  • 5Sφrlie T, Perou CM, Tibshirani R,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A, 2001, 98 ( 19 ) : 10869- 10874.
  • 6Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A, 2003,100(14) : 8418-8423.
  • 7Boecker W, Moll R, Dervan P, et al. Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ. J Pathol, 2002, 198(4) : 458-467.
  • 8Korsching E, Packeisen J, Agelopoulos K, et al. Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis. Lab Invest, 2002, 82 ( 11 ) : 1525-1533.
  • 9Tang P, Wang X, Schiffhauer L, et al. Relationship between nuclear grade of ductal carcinoma in situ and cell origin markers. Ann Clin Lab Sci, 2006, 36(1) : 16-22.
  • 10Laakso M, Loman N, Borg A, et al. Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors. Mod Pathol,2005,18(10) : 1321-1328.

共引文献72

同被引文献9

  • 1Satow R, Hirano T, Batori R,et al. Phospholipase C81 induces E- cadherin expression and suppresses malignancy in eolorectal cancer cells J]. Proe Natl Acad Sci USA ,2014,111 ( 37 ) : 13505 - 13510.
  • 2Yang H, Liu J, Yu H, el al. Expression and association of CD44v6 with prognosis in T2-3NOMO esophageal squamous cell carcinoma . J Thorac Dis,2014,6(2) :91 -98.
  • 3Wong TS, Gao W, Chan JY. Transcription regulation of E-cadherin by zinc finger E-box binding homeobox proteins in solid tumors [ J ]. Biomed Res Int,2014 ,2014 :921564.
  • 4Ahmadi L, Kamkari S, Mokarram P, et al. HER-2/neu and E-cadher- in Expression and Microsatellite Instability in Gastric Dysplasia[ J]. Middle East J Dig Dis,2011,3 ( 1 ) :20 - 27.
  • 5Chen J, Li T, Liu Q,et al. Clinical and prognostic significance of HIF-1 eL, PTEN, CD44v6, and survivin for gastric cancer : a meta-a- nalysis[ J. PLoS One ,2014,9 (3) : e91842.
  • 6Sullivan R, Graham CH. Hypoxia-driven selection of the metastatic phenotype[ J]. Cancer Metastasis Rev ,2007,26 ( 2 ) :319 - 331.
  • 7Yang H, Liu J, Yu H, et al. Expression and association of CD44v6 with prognosis in T2-3NOM0 esophageal squamous cell carcinoma [J]. J Thorac I)is,2014,6(2) :91 -98.
  • 8Nozoe T, Kohnoe S, Ezaki T, et al. Significance of immunohistochem- ical over-expression of CD44v6 as an indicator of malignant potential inesophageal squamous cell carcinoma [ I ]. J Cancer Res Clin On- col,2004,130 ( 6 ) :334 - 338.
  • 9Shen WD, Ji Y, Liu PF, et al. Correlation of E-cadherin and CD44v6 expression with clinical pathology in esophageal carcinoma [ J 1. Mol Med Rep,2012,5(3) :817 -821.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部